BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 8468921)

  • 1. Cytokines and mesangial cells.
    Sterzel RB; Schulze-Lohoff E; Marx M
    Kidney Int Suppl; 1993 Jan; 39():S26-31. PubMed ID: 8468921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesangial cell-matrix interactions. Effects on mesangial cell growth and cytokine secretion.
    Ruef C; Kashgarian M; Coleman DL
    Am J Pathol; 1992 Aug; 141(2):429-39. PubMed ID: 1323220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix-mesangial cell interaction modulates migration of macrophages.
    Singhal PC; Franki N; Gibbons N; Reddy K
    J Investig Med; 1998 Dec; 46(9):453-9. PubMed ID: 9861781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis and extracellular matrix-cell interactions in kidney disease.
    Makino H; Sugiyama H; Kashihara N
    Kidney Int Suppl; 2000 Sep; 77():S67-75. PubMed ID: 10997693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interaction of mesangial cells and the extracellular matrix in the glomerulus].
    Sterzel RB
    Verh Dtsch Ges Pathol; 1989; 73():36-8. PubMed ID: 2482621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors involved in the regulation of mesangial cell proliferation in vitro and in vivo.
    Floege J; Eng E; Young BA; Johnson RJ
    Kidney Int Suppl; 1993 Jan; 39():S47-54. PubMed ID: 8468926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesangial cell-matrix interactions: modulation of matrix expression in mesangial cells by extracellular matrices.
    Sakatsume M; Saito A; Takeda T; Yamazaki H; Narita I; Nishi S; Nakagawa Y; Arakawa M
    Exp Nephrol; 1995; 3(6):362-8. PubMed ID: 8528681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between glomerular mesangial cells, cytokines, and extracellular matrix.
    Sterzel RB; Schulze-Lohoff E; Weber M; Goodman SL
    J Am Soc Nephrol; 1992 Apr; 2(10 Suppl):S126-31. PubMed ID: 1600127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory mechanism in glomerular mesangial cell proliferation.
    Haas CS; Schöcklmann HO; Lang S; Kralewski M; Sterzel RB
    J Nephrol; 1999; 12(6):405-15. PubMed ID: 10626832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta (TGF-beta) stimulates the expression of beta1 integrins and adhesion by rat mesangial cells.
    Kagami S; Kuhara T; Yasutomo K; Okada K; Löster K; Reutter W; Kuroda Y
    Exp Cell Res; 1996 Nov; 229(1):1-6. PubMed ID: 8940242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of cytokines in osteoarthritis pathophysiology.
    Fernandes JC; Martel-Pelletier J; Pelletier JP
    Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptors for immune complexes activate gene expression and synthesis of matrix proteins in cultured rat and human mesangial cells: role of TGF-beta.
    López-Armada MJ; Gómez-Guerrero C; Egido J
    J Immunol; 1996 Sep; 157(5):2136-42. PubMed ID: 8757338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta 1 is the predominant paracrine inhibitor of macrophage cytokine synthesis produced by glomerular mesangial cells .
    Kitamura M; Sütö T; Yokoo T; Shimizu F; Fine LG
    J Immunol; 1996 Apr; 156(8):2964-71. PubMed ID: 8609417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential role of inflammatory and fibrogenic cytokines in the glomerular diseases.
    Ortiz A; Gómez-Chiarri M; Alonso J; Bustos C; Gómez-Guerrero C; López-Armada MJ; Gómez-Garre D; Palacios I; Ruíz-Ortega M; Gutierrez S
    J Lipid Mediat Cell Signal; 1994 Feb; 9(1):55-74. PubMed ID: 8032716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Glomerular extracellular matrix in glomerulosclerosis by molecular biology].
    Makino H
    Nihon Rinsho; 1992 Dec; 50(12):3038-45. PubMed ID: 1491457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple roles for platelet-derived growth factor in renal disease.
    Floege J; Johnson RJ
    Miner Electrolyte Metab; 1995; 21(4-5):271-82. PubMed ID: 7565476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of TGF-beta in glomerular diseases].
    Okuda S
    Nihon Rinsho; 1992 Dec; 50(12):3032-7. PubMed ID: 1491456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel interactions between TGF-{beta}1 actions and the 12/15-lipoxygenase pathway in mesangial cells.
    Kim YS; Xu ZG; Reddy MA; Li SL; Lanting L; Sharma K; Adler SG; Natarajan R
    J Am Soc Nephrol; 2005 Feb; 16(2):352-62. PubMed ID: 15615821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD40 ligand-activated human monocytes amplify glomerular inflammatory responses through soluble and cell-to-cell contact-dependent mechanisms.
    Kuroiwa T; Lee EG; Danning CL; Illei GG; McInnes IB; Boumpas DT
    J Immunol; 1999 Aug; 163(4):2168-75. PubMed ID: 10438958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of interleukin-1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis.
    Tesch GH; Lan HY; Atkins RC; Nikolic-Paterson DJ
    Am J Pathol; 1997 Jul; 151(1):141-50. PubMed ID: 9212740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.